707
Views
10
CrossRef citations to date
0
Altmetric
Clinical Research

Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 472-479 | Received 18 May 2020, Accepted 18 Sep 2020, Published online: 06 Nov 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ruben Goncalves, Magali Labadie, Simon Chouraqui, Alexandre Peyré, Nadège Castaing, Amélie Daveluy & Mathieu Molimard. (2022) Involuntary MDMB-4en-PINACA intoxications following cannabis consumption: clinical and analytical findings. Clinical Toxicology 60:4, pages 458-463.
Read now

Articles from other publishers (9)

Rose Crossin, Lana Cleland, Chris Wilkins, Marta Rychert, Simon Adamson, Tuari Potiki, Adam C Pomerleau, Blair MacDonald, Dwaine Faletanoai, Fiona Hutton, Geoff Noller, Ian Lambie, Jane L Sheridan, Jason George, Kali Mercier, Kristen Maynard, Louise Leonard, Patricia Walsh, Rhys Ponton, Sue Bagshaw, Suresh Muthukumaraswamy, Tracey McIntosh, Edward Poot, Paul Gordon, Patrick Sharry, David Nutt & Joseph Boden. (2023) The New Zealand drug harms ranking study: A multi-criteria decision analysis. Journal of Psychopharmacology 37:9, pages 891-903.
Crossref
B. Corso, A. Bacle, E. Demay, M. Mercerolle, R. Pelletier, T. Gicquel & B. Le Daré. (2023) Place of therapeutic cannabis in France and safety data: A literature review. Annales Pharmaceutiques Françaises.
Crossref
Hunter D. J. Webb, David B. Finlay, Shuli Chen, Andrea J. Vernall, Eric Sparkes, Samuel D. Banister, Rhonda J. Rosengren & Michelle Glass. (2022) Characterisation of AMB-FUBINACA metabolism and CB1-mediated activity of its acid metabolite. Forensic Toxicology 41:1, pages 114-125.
Crossref
Ali Sami Dheyab, Mohammed Qahtan Kanaan, Nabeel Abood Hussein, Mohamed Khalid AlOmar, Siti Fatimah Sabran & Mohd Fadzelly Abu Bakar. (2022) Antimycobacterial Activity of Rosmarinus officinalis (Rosemary) Extracted by Deep Eutectic Solvents. Separations 9:10, pages 271.
Crossref
Jack Markham, Eric Sparkes, Rochelle Boyd, Shuli Chen, Jamie J. Manning, David Finlay, Felcia Lai, Eila McGregor, Callan J. Maloney, Roy R. Gerona, Mark Connor, Iain S. McGregor, David E. Hibbs, Michelle Glass, Richard C. Kevin & Samuel D. Banister. (2022) Defining Steric Requirements at CB 1 and CB 2 Cannabinoid Receptors Using Synthetic Cannabinoid Receptor Agonists 5F-AB-PINACA, 5F-ADB-PINACA, PX-1, PX-2, NNL-1, and Their Analogues . ACS Chemical Neuroscience 13:8, pages 1281-1295.
Crossref
Claude Cyr, Mellar P. Davis, Danial Schecter & Paul DaeninckMellar P. Davis. 2022. Cannabis and Cannabinoid-Based Medicines in Cancer Care. Cannabis and Cannabinoid-Based Medicines in Cancer Care 91 115 .
Jamie J. Manning, Hayley M. Green, Michelle Glass & David B. Finlay. (2021) Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias. Neuropharmacology 193, pages 108611.
Crossref
Mingliang Lin, Beverly Ellis, Lisa M. Eubanks & Kim D. Janda. (2021) Pharmacokinetic Approach to Combat the Synthetic Cannabinoid PB-22. ACS Chemical Neuroscience 12:14, pages 2573-2579.
Crossref
Annelies Cannaert, Eric Sparkes, Edward Pike, Jia Lin Luo, Ada Fang, Richard C. Kevin, Ross Ellison, Roy Gerona, Samuel D. Banister & Christophe P. Stove. (2020) Synthesis and in Vitro Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A-CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA . ACS Chemical Neuroscience 11:24, pages 4434-4446.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.